CervicalMethDx Test
The CervicalMethDx Test identifies patients with aberrant DNA in genes associated with advanced cervical disease.
Our patent portfolio includes four filed patent applications (two granted), providing freedom to operate in the cervical cancer screening and triage space regardless of what sample type, or technological platform is used for testing.
Our precision methylation solutions can be administered at the point of care, and are compatible with in-home self-sampling and automated laboratory platforms. That means they can be used by physicians as an adjunct to routine physical examinations and screening procedures, using PCR, Mass Spec or NGS workflows.
CervicalMethDx Test
OralMethDx Test
GastricMethDx Test
Connect
Maryland
1812 Ashland Avenue
Garden Level G25P
Baltimore, MD 21205
Garden Level G25P
Baltimore, MD 21205
Puerto Rico
Carr 2, Km 18.6
Bo Candelaria
Toa Baja, Puerto Rico 00949
Bo Candelaria
Toa Baja, Puerto Rico 00949